EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Contribution of health history and neuropathologic changes to the likelihood of dementia in those with intermediate/high Alzheimer’s pathology: findings from The 90 + Study

Zarui A Melikyan, Zeinah Al-Darsani, Luohua Jiang, Katherine A Colcord, Annlia Paganini-Hill, Syed A Bukhari, Thomas J Montine, Claudia H Kawas, María M Corrada

Acta Neuropathologica · 06.04.2026 · 151 (1)

DOI: 10.1007/s00401-026-03010-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 06.04.2026. Verfasst von Zarui A Melikyan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology and Behavior, University of California, 1400 Bio Sci III, Irvine, CA, 92697, USA. zmelikya@uci.edu. Hauptthemen laut MEDLINE: Alzheimer Disease, Dementia, Brain. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although intermediate/high Alzheimer’s Disease Neuropathologic Change (ADNC) is associated with dementia in many older adults, some remain cognitively normal and are often referred to as resilient to ADNC. We aim to examine health, lifestyle, and neuropathologic factors that distinguish older adults with dementia vs. normal cognition in the presence of intermediate/high ADNC. Participants were from The 90 + Study , a longitudinal study of aging in southern California. This cross-sectional analysis included participants with an intermediate/high ADNC on neuropathologic exam and normal cognition or dementia diagnosis on case conference. We analyzed 11 neuropathologic changes, both vascular and neurodegenerative, dichotomized as present/absent, and the total number of neuropathologies. To examine the association of health and lifestyle factors and neuropathologic changes (predictors) with cognitive diagnosis at consensus case conference, dementia vs. normal cognition, (outcome), we used logistic regression adjusted for demographics. Among 235 participants (mean age at death = 98 years, 70% women), 33% maintained normal cognition. Participants with heart disease (OR = 0.45; 95% CI = 0.25, 0.81) and hypertension (OR = 0.53; 95% CI = 0.29, 0.95) had lower likelihood of dementia. In contrast, participants with a history of transient ischemic attacks (OR = 3.00; 95% CI = 1.46, 6.18), Lewy Body Disease (OR = 2.73; 95% CI = 1.14, 6.58), hippocampal sclerosis (OR = 2.70; 95% CI = 1.06, 6.86), Limbic-predominant Age-related TDP-43 Encephalopathy neuropathologic change (OR = 2.80; 95% CI = 1.53, 5.12), and a high number of non-ADNCs (OR = 4.46; 95% CI = 2.01, 9.92) had higher likelihood of dementia. Arteriolosclerosis, atherosclerosis, cerebral amyloid angiopathy, and microvascular lesions were not associated with dementia. In this study, the presence of neurodegenerative neuropathologic changes other than ADNC and the absence of hypertension distinguish oldest old individuals with dementia from those with normal cognition. Understanding mechanisms underlying normal cognition in those with ADNC may provide important clues to prevention and resilience to the effects of AD neuropathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDementiaBrainHumansFemaleMaleAged, 80 and overCross-Sectional StudiesLongitudinal StudiesAgingLife Style

Stichwörter der Autor:innen

Dementia vs. normal cognition in the presence of intermediate/high ADNCNeuropathologic changeNon-ADNCOldest old

Autor:innen und Institutionen

  • Department of Neurobiology and Behavior, University of California, 1400 Bio Sci III, Irvine, CA, 92697, USA. zmelikya@uci.edu.
  • Department of Epidemiology and Biostatistics, Temple University College of Public Health, 1210 W. Berks Street, 3Rd Floor Paley Hall, Philadelphia, PA, 19122, USA.
  • Department of Epidemiology and Biostatistics, University of California, 856 Health Sciences Road, Suite 3400, Irvine, CA, 92617, USA.
  • Institute for Memory Impairments and Neurological Disorders, University of California, 2642 Biological Sciences III, Irvine, CA, 92697, USA.
  • Beckman Laser Institute & Medical Clinic, University of California, 1002 Health Sciences Rd, Irvine, CA, 92612, USA.
  • Department of Pathology, Stanford University School of Medicine, Lane Building300 Pasteur Drive, Stanford, CA, L23594305, USA.

Förderung

  • NIA NIH HHS
  • National institutes of Health

Zitieren

APA

Melikyan, Z. A., Al-Darsani, Z., Jiang, L., Colcord, K. A., Paganini-Hill, A., Bukhari, S. A., Montine, T. J., Kawas, C. H., & Corrada, M. M. (2026). Contribution of health history and neuropathologic changes to the likelihood of dementia in those with intermediate/high Alzheimer’s pathology: findings from The 90 + Study. Acta Neuropathologica, 151(1). https://doi.org/10.1007/s00401-026-03010-9

Vancouver

Melikyan ZA, Al-Darsani Z, Jiang L, Colcord KA, Paganini-Hill A, Bukhari SA, et al. Contribution of health history and neuropathologic changes to the likelihood of dementia in those with intermediate/high Alzheimer’s pathology: findings from The 90 + Study. Acta Neuropathologica. 2026;151(1). doi:10.1007/s00401-026-03010-9

BibTeX
@article{Melikyan2026,
  author = {Melikyan, Zarui A and Al-Darsani, Zeinah and Jiang, Luohua and Colcord, Katherine A and Paganini-Hill, Annlia and Bukhari, Syed A and Montine, Thomas J and Kawas, Claudia H and Corrada, María M},
  title = {Contribution of health history and neuropathologic changes to the likelihood of dementia in those with intermediate/high Alzheimer’s pathology: findings from The 90 + Study},
  journal = {Acta Neuropathologica},
  year = {2026},
  volume = {151},
  number = {1},
  doi = {10.1007/s00401-026-03010-9}
}
Kostenlos starten →